OmniVis Awarded Booz Allen Foundation Innovation Fund Grant for Handheld SARS CoV-2 Detection
San Francisco, California, September 30, 2020
The Booz Allen Foundation, a 501(c)(3) organization dedicated to convening diverse stakeholders to solve challenging social issues, today announced the recipients of nearly $1 million in grants from the Booz Allen Foundation Innovation Fund.
OmniVis was selected to receive a grant for its innovative project – Handheld SARS-CoV-2 Detection
Established to support the development of creative solutions that address the wide-ranging impacts of the COVID-19 pandemic, the Booz Allen Foundation Innovation Fund was open to individuals, nonprofit organizations and eligible small businesses to apply from April 30 to June 5, 2020. Nearly 3,000 applications were submitted, coming from all 50 states, four U.S. territories and Washington, D.C.
Experience the power of the lab in the palm of your hand.
The 21 winners—including OmniVis— selected to receive grant funding are each working to develop new solutions, systems, technology and approaches that help build lasting community resilience by protecting vulnerable populations and frontline workers or support the safe return to work.
Innovation Fund grant applications were reviewed by over 150 individuals during a multi-tiered evaluation process. From 3,000 applications, 30 semi-finalists were selected to virtually pitch their projects to a team of external evaluators with backgrounds in innovation, grant making and entrepreneurship. The 21 winning teams were then evaluated and approved by the Booz Allen Foundation Board.
For a full list of Booz Allen Foundation Innovation Fund winners, visit https://boozallenfoundation.org/innovationfund/
About OmniVis
OmniVis, Inc is a biotechnology company that develops rapid disease diagnostic devices for communities around the world battling infectious disease. Its technology platform provides a quick, scalable and user-friendly approach to proactive disease detection with the ability to have the power of the lab in the palm of your hand to detect the presence of cholera bacteria in water in under 30 minutes. The company was founded based on CEO Katherine Clayton’s PhD research done at Purdue University.
About The Booz Allen Foundation
The Booz Allen Foundation was formed in 2017 as an independent 501(c)(3) tax-exempt organization. It serves as a convener of diverse stakeholders from the private, public, academic, and social sectors to solve challenging social issues through innovation and technology and build community resilience from the ground up. For more information visit https://boozallenfoundation.org.
PRESS CONTACTS
Lotte Vandewalle, lotte@omnivistech.com
Booz Allen Foundation Innovation Fund
Amanda Allison-Martini, Allison_Amanda@bah.com
